Brincidofovir: Difference between revisions

Brincidofovir
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

← Older edit Newer edit →

Revision as of 11:10, 15 February 2025

An antiviral medication used to treat certain viral infections

Brincidofovir is an antiviral drug that is used to treat certain viral infections. It is a lipid conjugate of cidofovir, designed to improve the delivery and efficacy of the drug while reducing its toxicity.

Mechanism of Action

Brincidofovir works by inhibiting viral DNA polymerase, an enzyme critical for viral DNA replication. By blocking this enzyme, brincidofovir prevents the virus from multiplying and spreading within the host organism.

Clinical Uses

Brincidofovir is primarily used in the treatment of infections caused by double-stranded DNA viruses, including:

It is particularly useful in immunocompromised patients, such as those undergoing hematopoietic stem cell transplantation.

Pharmacokinetics

Brincidofovir is administered orally and is absorbed into the bloodstream, where it is converted into its active form. The lipid conjugation allows for better cellular uptake and distribution, enhancing its antiviral activity while minimizing renal toxicity, a common side effect associated with cidofovir.

Side Effects

Common side effects of brincidofovir include:

Less common but serious side effects can include liver enzyme abnormalities and gastrointestinal disturbances.

Development and Approval

Brincidofovir was developed by Chimerix, a biopharmaceutical company. It has undergone various clinical trials to assess its efficacy and safety in treating viral infections. The drug has been granted orphan drug status for certain indications, reflecting its importance in treating rare conditions.

Related pages

@@ Line 1: / Line 1: @@
-'''Brincidofovir''' is an antiviral medication designed for the treatment of diseases caused by DNA viruses. This includes viruses such as [[smallpox]], [[adenovirus]], and certain strains of [[herpesviruses]]. Brincidofovir acts by inhibiting the DNA polymerase of these viruses, which is essential for viral replication. It is a lipid conjugate of cidofovir, which allows for enhanced cellular uptake and distribution, while also reducing nephrotoxicity—a significant side effect of cidofovir.
+{{Short description|An antiviral medication used to treat certain viral infections}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Brincidofovir_structure.svg
+| image2 =
+| width = 200px
+}}
+'''Brincidofovir''' is an [[antiviral drug]] that is used to treat certain [[viral infections]]. It is a lipid conjugate of [[cidofovir]], designed to improve the delivery and efficacy of the drug while reducing its toxicity.
 ==Mechanism of Action==
-Brincidofovir works by mimicking the natural nucleotides that DNA viruses use to replicate their DNA. When the virus attempts to use brincidofovir instead of its usual nucleotides, the drug is incorporated into the viral DNA. This incorporation leads to a premature termination of DNA synthesis, effectively halting the replication process of the virus. The lipid tail of brincidofovir facilitates its entry into cells and improves its antiviral activity while minimizing toxicity to the kidneys.
+Brincidofovir works by inhibiting viral [[DNA polymerase]], an enzyme critical for viral DNA replication. By blocking this enzyme, brincidofovir prevents the virus from multiplying and spreading within the host organism.
 ==Clinical Uses==
-Brincidofovir has been investigated for its potential use in treating various viral infections. It has shown promise in clinical trials for the treatment of [[cytomegalovirus]] (CMV) infections in patients who have undergone [[organ transplantation]], as these patients are at a high risk for viral infections due to immunosuppression. Additionally, its use has been explored in the treatment of adenovirus infections, which can be severe and potentially life-threatening in immunocompromised individuals.
+Brincidofovir is primarily used in the treatment of infections caused by [[double-stranded DNA viruses]], including:
-==Development and Approval==
+* [[Cytomegalovirus]] (CMV)
-The development of brincidofovir was motivated by the need for effective antiviral therapies with fewer side effects. Its potential for reduced nephrotoxicity made it a candidate for further development. Regulatory approval for brincidofovir has varied by region, with considerations based on its efficacy and safety profile in clinical trials. The drug has been granted orphan drug status for certain indications, reflecting its potential in treating rare and serious infections.
+* [[Adenovirus]]
+* [[Smallpox]]
+It is particularly useful in [[immunocompromised]] patients, such as those undergoing [[hematopoietic stem cell transplantation]].
+==Pharmacokinetics==
+Brincidofovir is administered orally and is absorbed into the bloodstream, where it is converted into its active form. The lipid conjugation allows for better cellular uptake and distribution, enhancing its antiviral activity while minimizing renal toxicity, a common side effect associated with cidofovir.
 ==Side Effects==
-While brincidofovir has been designed to reduce the nephrotoxicity associated with cidofovir, it is not without side effects. Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. There have also been reports of hematological abnormalities, including neutropenia and anemia, in patients receiving the drug. Monitoring for these side effects is an important part of the management of patients on brincidofovir.
+Common side effects of brincidofovir include:
-==Future Directions==
+* [[Diarrhea]]
-Research into brincidofovir continues, with studies exploring its efficacy against a broader range of DNA viruses and its potential use in different patient populations. The emergence of new viral pathogens and the ongoing challenge of managing infections in immunocompromised patients underscore the importance of developing versatile and safe antiviral medications.
+* [[Nausea]]
+* [[Vomiting]]
+Less common but serious side effects can include liver enzyme abnormalities and gastrointestinal disturbances.
+==Development and Approval==
+Brincidofovir was developed by [[Chimerix]], a biopharmaceutical company. It has undergone various clinical trials to assess its efficacy and safety in treating viral infections. The drug has been granted [[orphan drug]] status for certain indications, reflecting its importance in treating rare conditions.
+==Related pages==
+* [[Antiviral drug]]
+* [[Cidofovir]]
+* [[DNA polymerase]]
+* [[Immunocompromised]]
 [[Category:Antiviral drugs]]
-[[Category:Herpes]]
+[[Category:Organophosphates]]
-[[Category:Smallpox]]
+[[Category:Experimental drugs]]
-[[Category:Adenoviruses]]
-[[Category:Medicine stubs]]
-{{Medicine-stub}}
-{{No image}}